News & Views

  • Expert to Strengthen eCOA Offering
    Estelle Haenel

Expert to Strengthen eCOA Offering

Oct 12 2019 Read 777 Times

Clinical trials solutions provider Kayentis has appointed Estelle Haenel, PharmD,PhD as Medical Director, a role that includes facilitating both sites’ and patients’ adoption of eCOA (electronic Clinical Outcome Assessment) solutions as these technologies have matured.

With more than 25 years’ pharma industry experience, including 18 years in clinical science and operations, she will bring to the forefront of the company strategy the perspectives of patients, sites and customers. Improving overall patient engagement in clinical trials, will help pharmas, biotechs and CROs better meet the increasing regulatory requirements for more data and more patient-centric studies. The company’s new generation eCOA platform, Clin’form3, is designed to improve patient engagement, connection with medical devices and wearables, as well as BYOD implementation.
“Kayentis is delighted to welcome Estelle,” said Guillaume Juge, company CEO. “She brings extensive pharma industry experience and high-level skills that will consolidate our clinical knowledge, enhance our focus and reinforce the quality of care we provide to sites and patients. She will make a significant contribution to helping our customers across Europe, North America and Asia

design and implement robust digital trial data collection studies.

Concentrated on phases IIB/III the business is increasingly extending its services towards late phase studies and Real-World Evidence (RWE). It has conducted digital data collection for over 200 clinical trials in 75 countries (9,000 sites and 70,000 patients) employing 90 different languages in a broad range of therapeutic areas.

“Kayentis’ growth has been impressive. This is due to the quality, energy and dedication of its teams,” said Estelle Haenel. “In its positioning as 100% eCOA-focused, it has specially trained staff fully dedicated to preparing, delivering and maintaining eCOA solutions for customers. I have confidence in Kayentis’ high-quality and innovative eCOA solutions to support efficient clinical trials.”

Digital Edition

International Labmate February 2021

February 2021

In This Edition Articles - Expanding the Boundaries of Light Scattering for Macromolecules - Electrostatic Charges and Their Effects on Weighing - How the world’s most advanced analytical...

View all digital editions


SIAF Guangzhou

Mar 03 2021 Guanghzou, China


Mar 08 2021 Virtual Event

Bio-Europe Spring

Mar 22 2021 Digital event

Medtec Japan 2021

Apr 14 2021 Tokyo, Japan


Apr 20 2021 Virtual event

View all events